Gene · 2235
Papers1,987
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,987
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Current and Future Applications of 5-Aminolevulinic Acid in Neurosurgical Oncology. | Cancers (Basel) | 2025 | 40282508 | PubTator, text mining | PubMed |
| Modeling the Interactions Between Chemicals and Proteins to Predict the Health Consequences of Air Pollution. | Int J Environ Res Public Health | 2025 | 40238577 | PubTator, text mining | PubMed |
| Heme metabolism mediates RANKL-induced osteoclastogenesis via mitochondrial oxidative phosphorylation. | J Bone Miner Res | 2025 | 40073838 | PubTator, text mining | PubMed |
| Increased Mitochondrial Superoxide Level Is Partially Associated With Vemurafenib-Induced Renal Tubular Toxicity. | Basic Clin Pharmacol Toxicol | 2025 | 40018909 | PubTator, text mining | PubMed |
| Case Report: Cholestatic liver disease in the course of erythropoietic protoporphyria associated with renal hypodysplasia and atrial septal defect. | Front Pediatr | 2025 | 40007872 | PubTator, text mining | PubMed |
| RNA-Based Biomarkers of Iron Metabolism in Dried Blood Spots for Detecting Recombinant Human Erythropoietin in Doping Control. | Drug Test Anal | 2025 | 39976085 | PubTator, text mining | PubMed |
| Ferrochelatase Gene Variants Associated with Cholestasis in Adults: A Case Report. | J Clin Transl Hepatol | 2025 | 39917467 | PubTator, text mining | PubMed |
| The Neurodevelopmental Dynamics of Multilingual Experience During Childhood: A Longitudinal Behavioral, Structural, and Functional MRI Study. | Brain Sci | 2025 | 39851422 | PubTator, text mining | PubMed |
| Case report of anti-f(ce) antibody identified with unknown autoantibody from ABO discrepancy in a patient with liver cell carcinoma. | Transfus Apher Sci | 2025 | 39700841 | PubTator, text mining | PubMed |
| The Circadian Rhythm of Intracellular Protoporphyrin IX Accumulation Through Heme Synthesis Pathway in Bladder Urothelial Cancer Cells Exposed to 5-Aminolevulinic Acid. | Cancers (Basel) | 2024 | 39682298 | PubTator, text mining | PubMed |
| NFE2L2 and ferroptosis resistance in cancer therapy. | Cancer Drug Resist | 2024 | 39534872 | PubTator, text mining | PubMed |
| Metagenomic time series reveals a Western English Channel viral community dominated by members with strong seasonal signals. | ISME J | 2024 | 39441997 | PubTator, text mining | PubMed |
| Key Genes FECH and ALAS2 under Acute High-Altitude Exposure: A Gene Expression and Network Analysis Based on Expression Profile Data. | Genes (Basel) | 2024 | 39202434 | PubTator, text mining | PubMed |
| Molecular Determinants for Photodynamic Therapy Resistance and Improved Photosensitizer Delivery in Glioma. | Int J Mol Sci | 2024 | 39201395 | PubTator, text mining | PubMed |
| In Vitro Effect of Epigallocatechin Gallate on Heme Synthesis Pathway and Protoporphyrin IX Production. | Int J Mol Sci | 2024 | 39201369 | PubTator, text mining | PubMed |
| Case report: Xeroderma pigmentosum Group A with erythropoietic protoporphyria in a young Chinese patient. | Front Endocrinol (Lausanne) | 2024 | 39129919 | PubTator, text mining | PubMed |
| Trapping the substrate radical of heme synthase AhbD. | Front Chem | 2024 | 39119521 | PubTator, text mining | PubMed |
| Exploring the Antiangiogenic and Anti-Inflammatory Potential of Homoisoflavonoids: Target Identification Using Biotin Probes. | Biomolecules | 2024 | 39062499 | PubTator, text mining | PubMed |
| Direct Spectroscopic Ferrochelatase Assay. | Methods Mol Biol | 2024 | 39008258 | PubTator, text mining | PubMed |
| When the diagnosis is written in the DNA: a case of erythropoietic protoporphyria in a patient with a chromosome-18 deletion. | Dermatol Reports | 2024 | 38957628 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2235/papers?page=4